alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

118TH CONGRESS 

1ST SESSION H. R. 812 

To repeal the Inflation Reduction Act of 2022. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 2, 2023 

Mr. OGLES (for himself, Mr. PERRY, Mr. BIGGS, Mrs. MILLER of Illinois, Mr. 

JACKSON of Texas, Mr. BURLISON, Mr. GOOD of Virginia, Mrs. LUNA, 

Mr. DONALDS, Mr. BRECHEEN, Mr. BISHOP of North Carolina, Mr. 

ROSENDALE, Mr. SELF, Mr. ROY, Mr. CRANE, Mr. ROUZER, Mr. TIFFANY, Mr. ZINKE, Ms. HAGEMAN, Mr. CLOUD, and Mr. BUCK) introduced the following bill; which was referred to the Committee on Ways 

and Means, and in addition to the Committees on Energy and Commerce, 

Agriculture, Natural Resources, Financial Services, Science, Space, and 

Technology, Transportation and Infrastructure, and Oversight and Accountability, for a period to be subsequently determined by the Speaker, 

in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To repeal the Inflation Reduction Act of 2022. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Inflation Reduction 

5 Act of 2023’’. 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•HR 812 IH

1 SEC. 2. REPEAL OF INFLATION REDUCTION ACT OF 2022. 

2 (a) IN GENERAL.—Public Law 117–169 (commonly 

3 referred to as the Inflation Reduction Act of 2022) is re4 pealed. 

5 (b) RESCISSIONS.—The unobligated balances of any 

6 amounts made available under Public Law 117–169 are 

7 rescinded. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.9 Limitations of exemptions from section 510(k) of the Federal Food, Drug, and Cosmetic Act (the act). The exemption from the requirement of premarket notification (section 510(k) of the act) for a generic type of class I or II device is only to the extent that the device has existing or reasonably foreseeable characteristics of commercially distributed devices within that generic type or, in the case of in vitro diagnostic devices, only to the extent that misdiagnosis as a result of using the device would not be associated with high morbidity or mortality. Accordingly, manufacturers of any commercially distributed class I or II device for which FDA has granted an exemption from the requirement of premarket notification must still submit a premarket notification to FDA before introducing or delivering for introduction into interstate commerce for commercial distribution the device when: ( a ) The device is intended for a use different from the intended use of a legally marketed device in that generic type of device; e.g., the device is intended for a different medical purpose, or the device is intended for lay use where the former intended use was by health care professionals only;
( b ) The modified device operates using a different fundamental scientific technology than a legally marketed device in that generic type of device; e.g., a surgical instrument cuts tissue with a laser beam rather than with a sharpened metal blade, or an in vitro diagnostic device detects or identifies infectious agents by using deoxyribonucleic acid (DNA) probe or nucleic acid hybridization technology rather than culture or immunoassay technology; or
( c ) The device is an in vitro device that is intended: ( 1 ) For use in the diagnosis, monitoring, or screening of neoplastic diseases with the exception of immunohistochemical devices;
( 2 ) For use in screening or diagnosis of familial or acquired genetic disorders, including inborn errors of metabolism;
( 3 ) For measuring an analyte that serves as a surrogate marker for screening, diagnosis, or monitoring life-threatening diseases such as acquired immune deficiency syndrome (AIDS), chronic or active hepatitis, tuberculosis, or myocardial infarction or to monitor therapy;
( 4 ) For assessing the risk of cardiovascular diseases;
( 5 ) For use in diabetes management;
( 6 ) For identifying or inferring the identity of a microorganism directly from clinical material;
( 7 ) For detection of antibodies to microorganisms other than immunoglobulin G (IgG) or IgG assays when the results are not qualitative, or are used to determine immunity, or the assay is intended for use in matrices other than serum or plasma;
( 8 ) For noninvasive testing as defined in § 812.3(k) of this chapter; and
( 9 ) For near patient testing (point of care).
[65 FR 2319, Jan. 14, 2000]
Exhibit 10.2


                       ACCOUNTS PAYABLE DEFERRAL AGREEMENT
                       -----------------------------------


Recitals:

a. Pursuant to a Reorganization and Stock Purchase Agreement dated as of October
15, 2002 and effective as of October 24, 2002 (the  "Agreement"),  Soyo, Inc., a
Nevada corporation ("Soyo Nevada"),  became a wholly-owned subsidiary of Vermont
Witch Hazel Company, a Nevada corporation ("VWHC").

b. Soyo Nevada was previously a wholly-owned subsidiary of Soyo Computer,  Inc.,
a Taiwan company ("Soyo Taiwan").

c. Soyo Nevada is a distributor  of computer  parts and  components  provided by
Soyo Taiwan.

d. VWHC subsequently changed its name to Soyo Group, Inc. ("Soyo Group").

e.  In  conjunction   with  the  transaction  in  which  Soyo  Nevada  became  a
wholly-owned   subsidiary  of  Soyo  Group,   Soyo  Taiwan  acquired  shares  of
convertible preferred stock of Soyo Group ("Convertible Preferred Stock").

f. Soyo Nevada owed Soyo Taiwan  approximately  US$20,000,000 on open account as
of October 24, 2002 for the purchase of computer parts and components.

g. The parties  hereto  inadvertently  neglected  to include in the  Agreement a
payment  deferral  on a portion of the amount owed to Soyo Taiwan by Soyo Nevada
as of October 24, 2002.


The  parties  hereto  desire to amend the  Agreement  to include  the  following
provisions:

1. Soyo Taiwan  hereby  agrees to defer the payment of  US$12,000,000  due it by
Soyo Nevada.

2.  Soyo  Taiwan  hereby  agrees  to treat the  US$12,000,000  as an  unsecured,
non-interest bearing, long-term payable, due and payable on December 31, 2005.

3. Soyo Taiwan  hereby  acknowledges  and agrees that it will not be entitled to
any additional consideration for the deferral of the US$12,000,000.

4. The parties hereto agree that this Accounts Payable Deferral  Agreement shall
be deemed  effective  as of October 24, 2002,  upon the  execution by all of the
parties denoted below.


Additional provisions:

1. The parties hereto agree that this Accounts Payable Deferral Agreement may be
executed in one or more counterparts, each of which shall be deemed an original,
but all of which taken together shall constitute one and the same document.  For
purposes of execution of this Accounts  Payable Deferral  Agreement,  a document
signed and transmitted by facsimile machine or telecopier shall be treated as an
original document.


                                       1
<PAGE>

2. This Accounts Payable  Deferral  Agreement shall be construed and enforced in
accordance with the laws of the State of California. The prevailing party in any
dispute shall be entitled to  reimbursement  for reasonable  attorney's fees and
costs.


Acknowledged and Approved:


Soyo Group, Inc.
(formerly known as
Vermont Witch Hazel Company)


By: /s/Nancy Chu
   -------------------------

Title: CEO
      ----------------------


Soyo, Inc.


By: /s/ Nancy Chu
   -------------------------


Title: CEO
      ----------------------


Soyo Computer, Inc.


By: /s/Andy Chu
   -------------------------


Title: President
      ----------------------









                                       2
[Federal Register Volume 75, Number 45 (Tuesday, March 9, 2010)]
[Notices]
[Page 10755]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4920]


=======================================================================
-----------------------------------------------------------------------

COMMISSION ON CIVIL RIGHTS


Agenda and Notice of Public Meeting of the Arkansas Advisory 
Committee

    Notice is hereby given, pursuant to the provisions of the rules and 
regulations of the U.S. Commission on Civil Rights (Commission), and 
the Federal Advisory Committee Act (FACA), that a planning meeting of 
the Arkansas Advisory Committee to the Commission will convene by 
conference call at 2 p.m. and adjourn at approximately 3 p.m. on 
Thursday, April 8, 2010. The purpose of this meeting is to continue 
planning a civil rights project.
    This meeting is available to the public through the following toll-
free call-in number: (866) 364-7584, conference call access code number 
60378320. Any interested member of the public may call this number and 
listen to the meeting. Callers can expect to incur charges for calls 
they initiate over wireless lines, and the Commission will not refund 
any incurred charges. Callers will incur no charge for calls they 
initiate over land-line connections to the toll-free telephone number. 
Persons with hearing impairments may also follow the proceedings by 
first calling the Federal Relay Service at 1-800-977-8339 and providing 
the Service with the conference call number and contact name Farella E. 
Robinson.
    To ensure that the Commission secures an appropriate number of 
lines for the public, persons are asked to register by contacting 
Corrine Sanders of the Central Regional Office and TTY/TDD telephone 
number, by 4 p.m. on April 2, 2010.
    Members of the public are entitled to submit written comments. The 
comments must be received in the regional office by May 2, 2010. The 
address is U.S. Commission on Civil Rights, 400 State Avenue, Suite 
908, Kansas City, Kansas 66101. Comments may be e-mailed to 
<a href="/cdn-cgi/l/email-protection#d1b7a3beb3b8bfa2bebf91a4a2b2b2a3ffb6bea7"><span class="__cf_email__" data-cfemail="e98f9b868b80879a8687a99c9a8a8a9bc78e869f">[email protected]</span></a>. Records generated by this meeting may be inspected 
and reproduced at the Central Regional Office, as they become 
available, both before and after the meeting. Persons interested in the 
work of this advisory committee are advised to go to the Commission's 
Web site, http://www.usccr.gov, or to contact the Central Regional 
Office at the above email or street address.
    The meeting will be conducted pursuant to the provisions of the 
rules and regulations of the Commission and FACA.

    Dated in Washington, DC, March 4, 2010.
Peter Minarik, Acting Chief,
Regional Programs Coordination Unit.
[FR Doc. 2010-4920 Filed 3-8-10; 8:45 am]
BILLING CODE 6335-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7987 Referred in Senate (RFS)]

<DOC>
118th CONGRESS
  2d Session
                                H. R. 7987

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 30, 2024

 Received; read twice and referred to the Committee on Small Business 
                          and Entrepreneurship

_______________________________________________________________________

                                 AN ACT

 
  To require plain language and the inclusion of key words in covered 
   notices that are clear, concise, and accessible to small business 
                   concerns, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Plain Language in Contracting Act''.

SEC. 2. ACCESSIBILITY AND CLARITY IN COVERED NOTICES FOR SMALL BUSINESS 
              CONCERNS.

    (a) In General.--Each covered notice shall be written--
            (1) in a manner that is clear, concise, and accessible to a 
        small business concern; and
            (2) in a manner consistent, to the extent practicable, with 
        the Federal plain language guidelines established pursuant to 
        the Plain Writing Act of 2010 (5 U.S.C. 301 note).
    (b) Inclusion of Key Words in Covered Notices.--Each covered notice 
shall, to the maximum extent practicable, include key words in the 
description of the covered notice such that a small business concern 
seeking contract opportunities using the single governmentwide point of 
entry described under section 1708 of title 41, United States Code, can 
easily identify and understand such covered notice.
    (c) Rulemaking.--Not later than 90 days after the date of the 
enactment of this Act, the Administrator of the Small Business 
Administration shall issue rules to carry out this section.
    (d) Definitions.--In this section:
            (1) Covered notice.--The term ``covered notice'' means a 
        notice pertaining to small business concerns published by a 
        Federal agency on the single Government-wide point of entry 
        described under section 1708 of title 41, United States Code.
            (2) Small business act definitions.--The terms ``Federal 
        agency'' and ``small business concern'' have the meanings given 
        those terms, respectively, in section 3 of the Small Business 
        Act (15 U.S.C. 632).

SEC. 3. COMPLIANCE WITH CUTGO.

    No additional amounts are authorized to be appropriated to carry 
out this Act or the amendments made by this Act.

            Passed the House of Representatives April 29, 2024.

            Attest:

                                             KEVIN F. MCCUMBER,

                                                                 Clerk.
```
Exhibit 32.01



CERTIFICATION OF CHIEF EXECUTIVE OFFICER

REQUIRED BY RULE 13a-14(b) or RULE 15d-14(b)

AND SECTION 906 OF THE SARBANES-OXLEY ACT

OF 2002, 18 U.S.C. SECTION 1350



In connection with the Quarterly Report of Williams Controls, Inc (the "Company") on Form 10-Q for the period ended

June 30, 2006 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Patrick W. Cavanagh, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) |  | The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
| | --- |  | ---------------------------------------------------------------------------------------------------------------------

| | (2) |  | The
information contained in the Report fairly presents, in all material respects, the
financial condition and result of operations of the Company.
| | --- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------







/s/ PATRICK W. CAVANAGH

Patrick W. Cavanagh

Chief Executive Officer

Williams Controls, Inc.

August 10, 2006
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.5640 Medicinal nonventilatory nebulizer (atomizer). ( a ) *Identification.* A medicinal nonventilatory nebulizer (atomizer) is a device that is intended to spray liquid medication in aerosol form into the air that a patient will breathe.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 868.9.
[47 FR 31142, July 16, 1982, as amended at 65 FR 2313, Jan. 14, 2000]
Exhibit 35.3












ANNUAL STATEMENT AS TO COMPLIANCE

COMM 2015-CCRE25

The undersigned, David Co, a Director of Deutsche Bank Trust
Company Americas, as the Certificate Administrator (a “Certifying Servicer”) under the Pooling and Servicing Agreement,
dated as of August 1, 2015 (the “Agreement”), by and among, Deutsche Mortgage & Asset Receiving Corporation, as Depositor,
Wells Fargo Bank, National Association, as Master Servicer, CWCapital Asset Management LLC, as Special
Servicer, Wilmington Trust, National Association, as Trustee, Deutsche Bank Trust Company Americas, as Certificate Administrator, Paying
Agent and Custodian, and Pentalpha Surveillance LLC, as Operating Advisor, here by certifies in accordance with Section 10.11 of the Agreement:



| | A) | A review of such Certifying Servicer’s activities from August 1, 2015 to December 31, 2015 (the “reporting period”)
and of such Certifying Servicer’s performance under the Agreement has been made under such officer’s supervision and
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | B) | That, as to the best of such officer’s knowledge, based on such review, such Certifying Servicer has fulfilled all its
obligations under the Agreement, in all material respects throughout the reporting period.
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



DEUTSCHE BANK TRUST COMPANY AMERICAS

as Certificate Administrator





BY: David Co

Title: Director

Date: March 1, 2016
[if !vml]>[endif]>

[if !vml]>[endif]>

You have reached the FederalDepository Library Program Electronic Collection (FDLP/EC) Archive. Thisarchive assures ongoing access to publications in the FDLP/EC. Access topublications in the archive is available through GPO's suite of cataloging andlocator services, including the Catalog of U.S. Government Publications(CGP).  Archived copies of publications are retrieved in the event thatpublications are no longer available from the original publishing agency site. 
**Title:****La ventana en los valles : newsof the Valles Caldera National Preserve from the Board of Trustees.**
 
2009 | 2011 | 2012
 
SuDoc Number:
Item Number:
CGP systemNumber:
 
September 27, 2018
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.4150 Vitreous aspiration and cutting instrument. ( a ) *Identification.* A vitreous aspiration and cutting instrument is an electrically powered device, which may use ultrasound, intended to remove vitreous matter from the vitreous cavity or remove a crystalline lens.
( b ) *Classification.* Class II (special controls). The device, when it is phacofragmentation unit replacement tubing, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.
[52 FR 33355, Sept. 2, 1987, as amended at 84 FR 71817, Dec. 30, 2019]
38904.

#### CHANDLER v. ALABAMA POWER COMPANY.

Decided February 8, 1962.

Condemnation. Floyd Superior Court. Before Judge Hicks. *E. J. Clower, James Maddox,*for plaintiff in error.

*Matthews, Maddox, Walton & Smith, Oscar M. Smith, John W. Maddox,*contra.

Per Curiam.

The judgment of this court in *Chandler v. Alabama Power Co.,*104 Ga. App. 521 (122 SE2d 317), having been reversed by the Supreme Court of Georgia in *Alabama Poiuer Co. v. Chandler,*217 Ga. 550 (123 SE2d 767), the judgment of this court is vacated, and the judgment of the Supreme Court is made the judgment of this court.

*The judgment of the trial court is affirmed.*

*Felton, C. J., Bell and Hall, JJ., concur.*
#### § 1.1502-97 Special rules under section 382 for members under the jurisdiction of a court in a title 11 or similar case. [Reserved]
```

[115th Congress Public Law 15]
[From the U.S. Government Publishing Office]

[[Page 131 STAT. 79]]

Public Law 115-15
115th Congress

                                 An Act

 
 To amend title 4, United States Code, to encourage the display of the 
       flag of the United States on National Vietnam War Veterans 
                Day. <<NOTE: Mar. 28, 2017 -  [S. 305]>> 

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled, <<NOTE: Vietnam War 
Veterans Recognition Act of 2017. 4 USC 1 note.>> 
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Vietnam War Veterans Recognition Act 
of 2017''.
SEC. 2. DISPLAY OF FLAG ON NATIONAL VIETNAM WAR VETERANS DAY.

    Section 6(d) of title 4, United States Code, is amended by inserting 
``National Vietnam War Veterans Day, March 29;'' after ``third Monday in 
February;''.

    Approved March 28, 2017.

LEGISLATIVE HISTORY--S. 305:
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 163 (2017):
            Feb. 3, considered and passed Senate.
            Mar. 21, considered and passed House.

                                  <all>
```
#### State of Connecticut *v.*Rodger B. Berry

Argued February 6

decided February 6, 1968

*Jacob D. Zeldes,*with whom was *L. Douglas Shrader,*for the appellee (defendant).

*David B. Salzman,*assistant state’s attorney, for the appellant (state).

The motion by the defendant to dismiss the appeal from the Superior Court in New Haven County is denied.
Exhibit 13.2


FERRARI


CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I, Alessandro Gili, Chief Financial Officer of Ferrari N.V. (the “Company”), hereby certify pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:


|   |                                                                                                                                                                                                                                                                         
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|1. | the Company’s Annual Report on Form 20-F for the year ended December 31, 2014, to which this statement is furnished as an exhibit (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

|   |                                                                                                                                                     
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------
|2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.










Date: February 25, 2016/s/ Alessandro GiliAlessandro GiliChief Financial Officer











A signed original of this written statement has been provided to Ferrari N.V. and will be retained by Ferrari N.V. and furnished to the Securities and Exchange Commission or its staff upon request.


The foregoing certification is being furnished solely pursuant to 18 U.S.C §1350 and is not being filed as part of the Report or as a separate disclosure document.